Expert profile
Dr. Emma Wall
Clinician-researcher in infectious diseases and Long COVID
Long COVID • immune dysregulation • microvascular dysfunction • reverse-translation research • infectious diseases
1Discussion
52 minAnalysed
Related Health Areas
Topics discussed
About the expert
Focus: Patient-led reverse-translation research on Long COVID
Clinician-researcher affiliated with the Francis Crick Institute and University College London (UCL). Runs the UCL Long COVID clinic and serves as Principal Investigator on the Stimulate-ICP trial. Her work characterizes Long COVID as a patient-defined inflammatory illness driven by immune dysregulation and microvascular dysfunction, and pioneers a 'reverse-translation' research model that uses patient experiences to guide laboratory investigation.
Expert discussions with Dr. Emma Wall
Emma Wall on Long COVID as a patient-defined inflammatory disease
Long COVID may be best understood as a patient-defined inflammatory disease driven by immune dysregulation and microvascular dysfunction, not psychological factors. Even mild COVID infections can leave lasting physical effects including muscle damage and increased blood-brain barrier permeability. Research using patient experiences to guide laboratory investigation may identify precise drug targets faster than the traditional research-to-clinic direction.